Nanosensors detect cancer from whole blood
Nature Nanotechnology
December 14, 2009
Nanosensors that can detect early signs of disease from unprocessed whole blood are reported in a paper published online this week in Nature Nanotechnology. The sensors can be adapted for use with other physiological fluids, and are expected to be simple, quick and inexpensive enough to be used in the clinic, therefore avoiding the need for analysis by external labs.
Previous disease-marker detection work exposed nanosensors to carefully controlled purified solutions, rather than real physiological samples. The sensors developed by Mark Reed and colleagues combine separate purification and detection stages, allowing them to detect tiny amounts of cancer biomarkers in a small volume of whole blood in just 20 minutes.
doi: 10.1038/nnano.2009.353
Research highlights
-
Jul 22
Electronics: Plastic microprocessor flexes its powerNature
-
Jul 20
Astronomy: Event Horizon Telescope zooms in on another black holeNature Astronomy
-
Jul 15
Quantum computing: A step towards error-corrected quantum computersNature
-
Jul 6
Physics: ATLAS experiment measurements support universal truth of particle physicsNature Physics
-
Jul 6
Astronomy: Black holes throw their weight aroundNature Astronomy
-
Jul 1
Physics: The next generation of atomic clocks in spaceNature
